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Abstract
Introduction: Pulmonary arterial hypertension (PAH) is a rare but potentially fatal disease 
affecting 1-2 person/millions of population. Pulmonary artery remodeling has been established 
as a culprit in PAH development, and endothelial dysfunction is critically involved in the 
pathologic pulmonary artery remodeling; however, mechanisms underlying these pathologies 
remain unclear. In this study, we searched for genes preferentially expressed in the lung 
microvasculature that are potentially important for PAH development. 
Aim: To identify specifi c, potentially important genes in PAH pathogenesis and elucidate its 
mechanism.
Method:We performed DNA microarray analysis using RNAs of human endothelial cells (ECs) 
from various vascular beds as well as RNAs isolated from various organs including the lungs. 
After fi nding a candidate gene, we analyzed its effect on pulmonary artery ECs (hPAECs) 
functions through gene transfection using retrovirus. We also generated mice with targeted 
activation of the gene in ECs, and then produced PAH model through chronic exposure to 
hypoxia (10% O2 hypoxia for 3 weeks).
Results: Through the microarray analysis, we identifi ed one gene (gene-X) that is highly 
and preferentially expressed in human lung microvascular ECs. Overexpression of gene-X 
substantially reduced migration and tube formation capacities in hPAECs, while it enhanced 
endothelial apoptosis. Targeted activation of gene-X in ECs caused higher pulmonary arterial 
pressure even under normoxic condition, while hypoxia-induced PAH was exacerbated in these 
mice. 
Conclusion: Our data strongly suggest that gene-X plays a crucial role in PAH pathologies, 
and thus gene-X has a therapeutic potential for the treatment of PAH. 
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